Cowen Downgrades Raptor Pharmaceuticals (RPTP) to Market Perform

September 16, 2016 7:17 AM EDT
Get Alerts RPTP Hot Sheet
Price: $9.00 +0.33%

Rating Summary:
    7 Buy, 6 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 15 | Down: 13 | New: 71
Trade RPTP Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Cowen downgraded Raptor Pharmaceuticals (NASDAQ: RPTP) from Outperform to Market Perform with a price target of $9.00.

For an analyst ratings summary and ratings history on Raptor Pharmaceuticals click here. For more ratings news on Raptor Pharmaceuticals click here.

Shares of Raptor Pharmaceuticals closed at $8.98 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Downgrades

Related Entities

Cowen & Co

Add Your Comment